T. Rowe Price Associates’s IDEAYA Biosciences IDYA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $40M | Sell |
1,904,916
-1,570,706
| -45% | -$33M | ﹤0.01% | 786 |
|
|
2025
Q1 | $56.9M | Sell |
3,475,622
-391,286
| -10% | -$6.41M | 0.01% | 688 |
|
|
2024
Q4 | $99.4M | Sell |
3,866,908
-148,390
| -4% | -$3.81M | 0.01% | 566 |
|
|
2024
Q3 | $127M | Buy |
4,015,298
+271,557
| +7% | +$8.6M | 0.01% | 518 |
|
|
2024
Q2 | $131M | Sell |
3,743,741
-308,759
| -8% | -$10.8M | 0.02% | 486 |
|
|
2024
Q1 | $178M | Buy |
4,052,500
+486,222
| +14% | +$21.3M | 0.02% | 444 |
|
|
2023
Q4 | $127M | Buy |
3,566,278
+535,909
| +18% | +$19.1M | 0.02% | 499 |
|
|
2023
Q3 | $81.8M | Buy |
3,030,369
+527,696
| +21% | +$14.2M | 0.01% | 547 |
|
|
2023
Q2 | $58.8M | Buy |
2,502,673
+1,036,086
| +71% | +$24.3M | 0.01% | 653 |
|
|
2023
Q1 | $20.1M | Sell |
1,466,587
-196,941
| -12% | -$2.7M | ﹤0.01% | 919 |
|
|
2022
Q4 | $30.2M | Sell |
1,663,528
-195,349
| -11% | -$3.55M | ﹤0.01% | 807 |
|
|
2022
Q3 | $27.7M | Sell |
1,858,877
-27,375
| -1% | -$408K | ﹤0.01% | 812 |
|
|
2022
Q2 | $26M | Sell |
1,886,252
-228,741
| -11% | -$3.16M | ﹤0.01% | 1095 |
|
|
2022
Q1 | $23.7M | Sell |
2,114,993
-586,532
| -22% | -$6.56M | ﹤0.01% | 1191 |
|
|
2021
Q4 | $63.9M | Buy |
2,701,525
+365,619
| +16% | +$8.64M | 0.01% | 911 |
|
|
2021
Q3 | $59.5M | Buy |
2,335,906
+1,025,929
| +78% | +$26.2M | 0.01% | 950 |
|
|
2021
Q2 | $27.5M | Buy |
1,309,977
+409,712
| +46% | +$8.6M | ﹤0.01% | 1222 |
|
|
2021
Q1 | $21.2M | Buy |
900,265
+429,166
| +91% | +$10.1M | ﹤0.01% | 1261 |
|
|
2020
Q4 | $6.6M | Buy |
+471,099
| New | +$6.6M | ﹤0.01% | 1406 |
|